CN105324666B - 使用来自母体血液的胎儿细胞捕获的胎儿诊断学 - Google Patents
使用来自母体血液的胎儿细胞捕获的胎儿诊断学 Download PDFInfo
- Publication number
- CN105324666B CN105324666B CN201480027992.5A CN201480027992A CN105324666B CN 105324666 B CN105324666 B CN 105324666B CN 201480027992 A CN201480027992 A CN 201480027992A CN 105324666 B CN105324666 B CN 105324666B
- Authority
- CN
- China
- Prior art keywords
- sample
- cells
- cell
- fetal
- stationary phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000001605 fetal effect Effects 0.000 title claims abstract description 217
- 230000008774 maternal effect Effects 0.000 title claims abstract description 146
- 239000008280 blood Substances 0.000 title claims description 25
- 210000004369 blood Anatomy 0.000 title claims description 24
- 238000003745 diagnosis Methods 0.000 title abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 110
- 230000014509 gene expression Effects 0.000 claims abstract description 109
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 107
- 239000002773 nucleotide Substances 0.000 claims abstract description 76
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 75
- 210000003754 fetus Anatomy 0.000 claims abstract description 66
- 210000004027 cell Anatomy 0.000 claims description 420
- 239000000523 sample Substances 0.000 claims description 329
- 230000005526 G1 to G0 transition Effects 0.000 claims description 78
- 108020004707 nucleic acids Proteins 0.000 claims description 60
- 150000007523 nucleic acids Chemical class 0.000 claims description 60
- 102000039446 nucleic acids Human genes 0.000 claims description 60
- -1 β-hCG Proteins 0.000 claims description 35
- 238000012163 sequencing technique Methods 0.000 claims description 31
- 108010076557 Matrix Metalloproteinase 14 Proteins 0.000 claims description 27
- 102000011716 Matrix Metalloproteinase 14 Human genes 0.000 claims description 26
- 238000000926 separation method Methods 0.000 claims description 25
- 238000004458 analytical method Methods 0.000 claims description 23
- 102000028180 Glycophorins Human genes 0.000 claims description 22
- 108091005250 Glycophorins Proteins 0.000 claims description 22
- 102100032859 Protein AMBP Human genes 0.000 claims description 22
- 101000797623 Homo sapiens Protein AMBP Proteins 0.000 claims description 21
- 108010075843 alpha-2-HS-Glycoprotein Proteins 0.000 claims description 21
- 108010045374 CD36 Antigens Proteins 0.000 claims description 20
- 102000012005 alpha-2-HS-Glycoprotein Human genes 0.000 claims description 20
- 239000002458 cell surface marker Substances 0.000 claims description 20
- 102000003846 Carbonic anhydrases Human genes 0.000 claims description 19
- 108090000209 Carbonic anhydrases Proteins 0.000 claims description 19
- 210000003743 erythrocyte Anatomy 0.000 claims description 19
- 102100030802 Beta-2-glycoprotein 1 Human genes 0.000 claims description 18
- 101000793425 Homo sapiens Beta-2-glycoprotein 1 Proteins 0.000 claims description 18
- 101000976697 Homo sapiens Inter-alpha-trypsin inhibitor heavy chain H1 Proteins 0.000 claims description 18
- 102100023490 Inter-alpha-trypsin inhibitor heavy chain H1 Human genes 0.000 claims description 18
- 102100035023 Carboxypeptidase B2 Human genes 0.000 claims description 17
- 102000049320 CD36 Human genes 0.000 claims description 16
- 102100030826 Hemoglobin subunit epsilon Human genes 0.000 claims description 16
- 102100034629 Hemopexin Human genes 0.000 claims description 16
- 101001083591 Homo sapiens Hemoglobin subunit epsilon Proteins 0.000 claims description 16
- 101001067323 Homo sapiens Hemopexin Proteins 0.000 claims description 16
- 102100023635 Alpha-fetoprotein Human genes 0.000 claims description 15
- 102100022977 Antithrombin-III Human genes 0.000 claims description 15
- 102100040202 Apolipoprotein B-100 Human genes 0.000 claims description 15
- 102100028967 HLA class I histocompatibility antigen, alpha chain G Human genes 0.000 claims description 15
- 108010024164 HLA-G Antigens Proteins 0.000 claims description 15
- 101000757319 Homo sapiens Antithrombin-III Proteins 0.000 claims description 15
- 101000889953 Homo sapiens Apolipoprotein B-100 Proteins 0.000 claims description 15
- 101000946518 Homo sapiens Carboxypeptidase B2 Proteins 0.000 claims description 15
- 101710123134 Ice-binding protein Proteins 0.000 claims description 15
- 101710082837 Ice-structuring protein Proteins 0.000 claims description 15
- 108020004440 Thymidine kinase Proteins 0.000 claims description 15
- 101710107540 Type-2 ice-structuring protein Proteins 0.000 claims description 15
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 claims description 15
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 claims description 15
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 claims description 15
- 102100030970 Apolipoprotein C-III Human genes 0.000 claims description 14
- 101000793223 Homo sapiens Apolipoprotein C-III Proteins 0.000 claims description 14
- 102000006601 Thymidine Kinase Human genes 0.000 claims description 13
- 239000011324 bead Substances 0.000 claims description 13
- 210000000130 stem cell Anatomy 0.000 claims description 13
- 101710186708 Agglutinin Proteins 0.000 claims description 11
- 101710146024 Horcolin Proteins 0.000 claims description 11
- 101710189395 Lectin Proteins 0.000 claims description 11
- 101710179758 Mannose-specific lectin Proteins 0.000 claims description 11
- 101710150763 Mannose-specific lectin 1 Proteins 0.000 claims description 11
- 101710150745 Mannose-specific lectin 2 Proteins 0.000 claims description 11
- 239000000910 agglutinin Substances 0.000 claims description 11
- 238000009396 hybridization Methods 0.000 claims description 11
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 claims description 9
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 238000005119 centrifugation Methods 0.000 claims description 8
- 235000013601 eggs Nutrition 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 238000001712 DNA sequencing Methods 0.000 claims description 5
- 239000011159 matrix material Substances 0.000 claims description 5
- 102100031574 Platelet glycoprotein 4 Human genes 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- XOHUEYCVLUUEJJ-UHFFFAOYSA-N 2,3-Bisphosphoglyceric acid Chemical compound OP(=O)(O)OC(C(=O)O)COP(O)(O)=O XOHUEYCVLUUEJJ-UHFFFAOYSA-N 0.000 claims description 3
- 230000000717 retained effect Effects 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 2
- 229910052751 metal Inorganic materials 0.000 claims description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims 1
- 102000005741 Metalloproteases Human genes 0.000 claims 1
- 108010006035 Metalloproteases Proteins 0.000 claims 1
- 229960004424 carbon dioxide Drugs 0.000 claims 1
- 235000011089 carbon dioxide Nutrition 0.000 claims 1
- 108020004414 DNA Proteins 0.000 description 41
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 29
- 238000001514 detection method Methods 0.000 description 26
- 102000004169 proteins and genes Human genes 0.000 description 16
- 230000035935 pregnancy Effects 0.000 description 15
- 239000003550 marker Substances 0.000 description 13
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 12
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 12
- 210000000349 chromosome Anatomy 0.000 description 12
- 238000000137 annealing Methods 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 8
- 230000003321 amplification Effects 0.000 description 8
- 239000002299 complementary DNA Substances 0.000 description 8
- 238000000432 density-gradient centrifugation Methods 0.000 description 8
- 238000003199 nucleic acid amplification method Methods 0.000 description 8
- 239000008055 phosphate buffer solution Substances 0.000 description 8
- 238000003757 reverse transcription PCR Methods 0.000 description 8
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 7
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 7
- 108091028043 Nucleic acid sequence Proteins 0.000 description 7
- 102100032420 Protein S100-A9 Human genes 0.000 description 7
- 238000009826 distribution Methods 0.000 description 7
- 239000000975 dye Substances 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 208000011580 syndromic disease Diseases 0.000 description 7
- IGAZHQIYONOHQN-UHFFFAOYSA-N Alexa Fluor 555 Chemical compound C=12C=CC(=N)C(S(O)(=O)=O)=C2OC2=C(S(O)(=O)=O)C(N)=CC=C2C=1C1=CC=C(C(O)=O)C=C1C(O)=O IGAZHQIYONOHQN-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 238000013459 approach Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 210000002381 plasma Anatomy 0.000 description 6
- 102000005962 receptors Human genes 0.000 description 6
- 108020003175 receptors Proteins 0.000 description 6
- 239000013074 reference sample Substances 0.000 description 6
- 108010048090 soybean lectin Proteins 0.000 description 6
- 101150003725 TK gene Proteins 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 5
- 238000007901 in situ hybridization Methods 0.000 description 5
- 108020004999 messenger RNA Proteins 0.000 description 5
- 239000011049 pearl Substances 0.000 description 5
- 239000002243 precursor Substances 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 4
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 4
- 102000003886 Glycoproteins Human genes 0.000 description 4
- 108090000288 Glycoproteins Proteins 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 229920001213 Polysorbate 20 Polymers 0.000 description 4
- 230000027455 binding Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000002771 cell marker Substances 0.000 description 4
- 230000002559 cytogenic effect Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000012252 genetic analysis Methods 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 4
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 102100028042 Alpha-2-HS-glycoprotein Human genes 0.000 description 3
- 108091093088 Amplicon Proteins 0.000 description 3
- 101150102415 Apob gene Proteins 0.000 description 3
- 108010071619 Apolipoproteins Proteins 0.000 description 3
- 102000007592 Apolipoproteins Human genes 0.000 description 3
- 108090000087 Carboxypeptidase B Proteins 0.000 description 3
- 102000003670 Carboxypeptidase B Human genes 0.000 description 3
- 102100031196 Choriogonadotropin subunit beta 3 Human genes 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- 238000000018 DNA microarray Methods 0.000 description 3
- 101001060288 Homo sapiens Alpha-2-HS-glycoprotein Proteins 0.000 description 3
- 101000776619 Homo sapiens Choriogonadotropin subunit beta 3 Proteins 0.000 description 3
- 229910020769 KISS1 Inorganic materials 0.000 description 3
- 102000019298 Lipocalin Human genes 0.000 description 3
- 108050006654 Lipocalin Proteins 0.000 description 3
- 208000036878 aneuploidy Diseases 0.000 description 3
- 206010003883 azoospermia Diseases 0.000 description 3
- 239000000090 biomarker Substances 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 238000010195 expression analysis Methods 0.000 description 3
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 3
- 239000002777 nucleoside Substances 0.000 description 3
- 125000003835 nucleoside group Chemical group 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 210000003765 sex chromosome Anatomy 0.000 description 3
- 101710153593 Albumin A Proteins 0.000 description 2
- IKYJCHYORFJFRR-UHFFFAOYSA-N Alexa Fluor 350 Chemical compound O=C1OC=2C=C(N)C(S(O)(=O)=O)=CC=2C(C)=C1CC(=O)ON1C(=O)CCC1=O IKYJCHYORFJFRR-UHFFFAOYSA-N 0.000 description 2
- JLDSMZIBHYTPPR-UHFFFAOYSA-N Alexa Fluor 405 Chemical compound CC[NH+](CC)CC.CC[NH+](CC)CC.CC[NH+](CC)CC.C12=C3C=4C=CC2=C(S([O-])(=O)=O)C=C(S([O-])(=O)=O)C1=CC=C3C(S(=O)(=O)[O-])=CC=4OCC(=O)N(CC1)CCC1C(=O)ON1C(=O)CCC1=O JLDSMZIBHYTPPR-UHFFFAOYSA-N 0.000 description 2
- WEJVZSAYICGDCK-UHFFFAOYSA-N Alexa Fluor 430 Chemical compound CC[NH+](CC)CC.CC1(C)C=C(CS([O-])(=O)=O)C2=CC=3C(C(F)(F)F)=CC(=O)OC=3C=C2N1CCCCCC(=O)ON1C(=O)CCC1=O WEJVZSAYICGDCK-UHFFFAOYSA-N 0.000 description 2
- 239000012103 Alexa Fluor 488 Substances 0.000 description 2
- WHVNXSBKJGAXKU-UHFFFAOYSA-N Alexa Fluor 532 Chemical compound [H+].[H+].CC1(C)C(C)NC(C(=C2OC3=C(C=4C(C(C(C)N=4)(C)C)=CC3=3)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=C2C=3C(C=C1)=CC=C1C(=O)ON1C(=O)CCC1=O WHVNXSBKJGAXKU-UHFFFAOYSA-N 0.000 description 2
- ZAINTDRBUHCDPZ-UHFFFAOYSA-M Alexa Fluor 546 Chemical compound [H+].[Na+].CC1CC(C)(C)NC(C(=C2OC3=C(C4=NC(C)(C)CC(C)C4=CC3=3)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=C2C=3C(C(=C(Cl)C=1Cl)C(O)=O)=C(Cl)C=1SCC(=O)NCCCCCC(=O)ON1C(=O)CCC1=O ZAINTDRBUHCDPZ-UHFFFAOYSA-M 0.000 description 2
- 239000012109 Alexa Fluor 568 Substances 0.000 description 2
- 108090000201 Carboxypeptidase B2 Proteins 0.000 description 2
- 208000032170 Congenital Abnormalities Diseases 0.000 description 2
- 201000010374 Down Syndrome Diseases 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 229920001917 Ficoll Polymers 0.000 description 2
- 108010015776 Glucose oxidase Proteins 0.000 description 2
- 239000004366 Glucose oxidase Substances 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- 102000013271 Hemopexin Human genes 0.000 description 2
- 108010026027 Hemopexin Proteins 0.000 description 2
- 101000838236 Homo sapiens T-complex protein 11-like protein 2 Proteins 0.000 description 2
- 201000004408 Hypobetalipoproteinemia Diseases 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 208000017493 Pelizaeus-Merzbacher disease Diseases 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 108091093037 Peptide nucleic acid Proteins 0.000 description 2
- 108010004729 Phycoerythrin Proteins 0.000 description 2
- 108020004682 Single-Stranded DNA Proteins 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- 102100028608 T-complex protein 11-like protein 2 Human genes 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- WLDHEUZGFKACJH-UHFFFAOYSA-K amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1N=NC1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-UHFFFAOYSA-K 0.000 description 2
- 230000003322 aneuploid effect Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 102000005936 beta-Galactosidase Human genes 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 238000002509 fluorescent in situ hybridization Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 229940116332 glucose oxidase Drugs 0.000 description 2
- 235000019420 glucose oxidase Nutrition 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000006249 magnetic particle Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002493 microarray Methods 0.000 description 2
- 208000030454 monosomy Diseases 0.000 description 2
- 210000003924 normoblast Anatomy 0.000 description 2
- 238000003793 prenatal diagnosis Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 238000004393 prognosis Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- YQMUORJJDBQCOV-UHFFFAOYSA-N $l^{1}-phosphanylmethane Chemical compound [P]C YQMUORJJDBQCOV-UHFFFAOYSA-N 0.000 description 1
- LTCPEIRUSSPBJB-UHFFFAOYSA-N 2,3-dihydroxypropanoic acid;phosphoric acid Chemical compound OP(O)(O)=O.OCC(O)C(O)=O LTCPEIRUSSPBJB-UHFFFAOYSA-N 0.000 description 1
- IOOMXAQUNPWDLL-UHFFFAOYSA-N 2-[6-(diethylamino)-3-(diethyliminiumyl)-3h-xanthen-9-yl]-5-sulfobenzene-1-sulfonate Chemical compound C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S(O)(=O)=O)C=C1S([O-])(=O)=O IOOMXAQUNPWDLL-UHFFFAOYSA-N 0.000 description 1
- 101150039504 6 gene Proteins 0.000 description 1
- 239000012104 Alexa Fluor 500 Substances 0.000 description 1
- 239000012105 Alexa Fluor 514 Substances 0.000 description 1
- 239000012110 Alexa Fluor 594 Substances 0.000 description 1
- 239000012111 Alexa Fluor 610 Substances 0.000 description 1
- 239000012112 Alexa Fluor 633 Substances 0.000 description 1
- 239000012114 Alexa Fluor 647 Substances 0.000 description 1
- 239000012115 Alexa Fluor 660 Substances 0.000 description 1
- 239000012116 Alexa Fluor 680 Substances 0.000 description 1
- 239000012117 Alexa Fluor 700 Substances 0.000 description 1
- 239000012118 Alexa Fluor 750 Substances 0.000 description 1
- 206010002961 Aplasia Diseases 0.000 description 1
- 208000002109 Argyria Diseases 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 102100035024 Carboxypeptidase B Human genes 0.000 description 1
- 102000005367 Carboxypeptidases Human genes 0.000 description 1
- 108010006303 Carboxypeptidases Proteins 0.000 description 1
- 108010080937 Carboxypeptidases A Proteins 0.000 description 1
- 102000000496 Carboxypeptidases A Human genes 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 208000010693 Charcot-Marie-Tooth Disease Diseases 0.000 description 1
- 108010004103 Chylomicrons Proteins 0.000 description 1
- 102100036213 Collagen alpha-2(I) chain Human genes 0.000 description 1
- 102100030886 Complement receptor type 1 Human genes 0.000 description 1
- 230000007067 DNA methylation Effects 0.000 description 1
- 208000000398 DiGeorge Syndrome Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 201000006360 Edwards syndrome Diseases 0.000 description 1
- 201000009273 Endometriosis Diseases 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- SPJOZZSIXXJYBT-UHFFFAOYSA-N Fenson Chemical compound C1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=CC=C1 SPJOZZSIXXJYBT-UHFFFAOYSA-N 0.000 description 1
- 101710145505 Fiber protein Proteins 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 101100438614 Homo sapiens CPB1 gene Proteins 0.000 description 1
- 101000875067 Homo sapiens Collagen alpha-2(I) chain Proteins 0.000 description 1
- 101000727061 Homo sapiens Complement receptor type 1 Proteins 0.000 description 1
- 101001038874 Homo sapiens Glycoprotein hormones alpha chain Proteins 0.000 description 1
- 101000868279 Homo sapiens Leukocyte surface antigen CD47 Proteins 0.000 description 1
- 101000917826 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor II-a Proteins 0.000 description 1
- 101000917824 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor II-b Proteins 0.000 description 1
- 101001091223 Homo sapiens Metastasis-suppressor KiSS-1 Proteins 0.000 description 1
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 1
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 201000007493 Kallmann syndrome Diseases 0.000 description 1
- 208000017924 Klinefelter Syndrome Diseases 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 102100032913 Leukocyte surface antigen CD47 Human genes 0.000 description 1
- 102100029204 Low affinity immunoglobulin gamma Fc region receptor II-a Human genes 0.000 description 1
- 102100030216 Matrix metalloproteinase-14 Human genes 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 108030000089 Metallocarboxypeptidases Proteins 0.000 description 1
- 102000006166 Metallocarboxypeptidases Human genes 0.000 description 1
- 102100034841 Metastasis-suppressor KiSS-1 Human genes 0.000 description 1
- 208000009795 Microphthalmos Diseases 0.000 description 1
- 108020005196 Mitochondrial DNA Proteins 0.000 description 1
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 1
- 101100346932 Mus musculus Muc1 gene Proteins 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 208000009905 Neurofibromatoses Diseases 0.000 description 1
- 108010035916 Nuclear Matrix-Associated Proteins Proteins 0.000 description 1
- 102000008297 Nuclear Matrix-Associated Proteins Human genes 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 206010053142 Olfacto genital dysplasia Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 238000009004 PCR Kit Methods 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 239000012807 PCR reagent Substances 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 201000009928 Patau syndrome Diseases 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 108010046644 Polymeric Immunoglobulin Receptors Proteins 0.000 description 1
- 102100035187 Polymeric immunoglobulin receptor Human genes 0.000 description 1
- 208000020584 Polyploidy Diseases 0.000 description 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 1
- 206010036590 Premature baby Diseases 0.000 description 1
- 206010036600 Premature labour Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 238000001190 Q-PCR Methods 0.000 description 1
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 108010017842 Telomerase Proteins 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- 208000035199 Tetraploidy Diseases 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- GYDJEQRTZSCIOI-UHFFFAOYSA-N Tranexamic acid Chemical compound NCC1CCC(C(O)=O)CC1 GYDJEQRTZSCIOI-UHFFFAOYSA-N 0.000 description 1
- 108010015865 Transferrins Proteins 0.000 description 1
- 102000002070 Transferrins Human genes 0.000 description 1
- 206010044686 Trisomy 13 Diseases 0.000 description 1
- 208000006284 Trisomy 13 Syndrome Diseases 0.000 description 1
- 208000007159 Trisomy 18 Syndrome Diseases 0.000 description 1
- 208000026928 Turner syndrome Diseases 0.000 description 1
- 206010049644 Williams syndrome Diseases 0.000 description 1
- 201000001305 Williams-Beuren syndrome Diseases 0.000 description 1
- 208000006254 Wolf-Hirschhorn Syndrome Diseases 0.000 description 1
- 210000001766 X chromosome Anatomy 0.000 description 1
- 208000001001 X-linked ichthyosis Diseases 0.000 description 1
- 210000002593 Y chromosome Anatomy 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 231100001075 aneuploidy Toxicity 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 231100000693 bioaccumulation Toxicity 0.000 description 1
- 210000002298 blastodisc Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910000085 borane Inorganic materials 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000006727 cell loss Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- VYXSBFYARXAAKO-WTKGSRSZSA-N chembl402140 Chemical compound Cl.C1=2C=C(C)C(NCC)=CC=2OC2=C\C(=N/CC)C(C)=CC2=C1C1=CC=CC=C1C(=O)OCC VYXSBFYARXAAKO-WTKGSRSZSA-N 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 101150116409 dys-1 gene Proteins 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 108010046015 ferritin receptor Proteins 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 108091008053 gene clusters Proteins 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 238000013412 genome amplification Methods 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 201000003702 glycerol kinase deficiency Diseases 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 239000000833 heterodimer Substances 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000003365 immunocytochemistry Methods 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 238000012744 immunostaining Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 208000026203 inborn glycerol kinase deficiency Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- NTHXOOBQLCIOLC-UHFFFAOYSA-N iohexol Chemical compound OCC(O)CN(C(=O)C)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NTHXOOBQLCIOLC-UHFFFAOYSA-N 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 201000010478 microphthalmia Diseases 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 201000004931 neurofibromatosis Diseases 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 238000012576 optical tweezer Methods 0.000 description 1
- 201000003738 orofaciodigital syndrome VIII Diseases 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- VYNDHICBIRRPFP-UHFFFAOYSA-N pacific blue Chemical compound FC1=C(O)C(F)=C2OC(=O)C(C(=O)O)=CC2=C1 VYNDHICBIRRPFP-UHFFFAOYSA-N 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- KWVYZVYHZCFYIY-UHFFFAOYSA-N phyllochlorin Chemical compound N1C(C=C2C(C(CCC(=O)OC)C(=N2)C(C)=C2NC(=C3)C(C)=C2)C)=C(C)C(C=C)=C1C=C1C(C)=C(CC)C3=N1 KWVYZVYHZCFYIY-UHFFFAOYSA-N 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 201000011461 pre-eclampsia Diseases 0.000 description 1
- 208000026440 premature labor Diseases 0.000 description 1
- 208000012934 primary antiphospholipid syndrome Diseases 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 208000026079 recessive X-linked ichthyosis Diseases 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 239000001044 red dye Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 239000010458 rotten stone Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 108010059841 serine carboxypeptidase Proteins 0.000 description 1
- 239000003001 serine protease inhibitor Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- WGTODYJZXSJIAG-UHFFFAOYSA-N tetramethylrhodamine chloride Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C(O)=O WGTODYJZXSJIAG-UHFFFAOYSA-N 0.000 description 1
- JGVWCANSWKRBCS-UHFFFAOYSA-N tetramethylrhodamine thiocyanate Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=C(SC#N)C=C1C(O)=O JGVWCANSWKRBCS-UHFFFAOYSA-N 0.000 description 1
- 208000027223 tetraploidy syndrome Diseases 0.000 description 1
- 208000011908 tetrasomy Diseases 0.000 description 1
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 230000025366 tissue development Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 206010053884 trisomy 18 Diseases 0.000 description 1
- 210000000251 trophoblastic cell Anatomy 0.000 description 1
- 108010088854 urinastatin Proteins 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70582—CD71
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
- G01N2333/96491—Metalloendopeptidases (3.4.24) with definite EC number
- G01N2333/96494—Matrix metalloproteases, e. g. 3.4.24.7
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
Description
Claims (51)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361824128P | 2013-05-16 | 2013-05-16 | |
US61/824,128 | 2013-05-16 | ||
PCT/US2014/038250 WO2014186607A1 (en) | 2013-05-16 | 2014-05-15 | Fetal diagnostics using fetal cell capture from maternal blood |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105324666A CN105324666A (zh) | 2016-02-10 |
CN105324666B true CN105324666B (zh) | 2018-07-27 |
Family
ID=51898880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201480027992.5A Active CN105324666B (zh) | 2013-05-16 | 2014-05-15 | 使用来自母体血液的胎儿细胞捕获的胎儿诊断学 |
Country Status (10)
Country | Link |
---|---|
US (1) | US20160053317A1 (zh) |
EP (1) | EP2997370A4 (zh) |
JP (1) | JP2016521134A (zh) |
KR (1) | KR20160007542A (zh) |
CN (1) | CN105324666B (zh) |
AU (1) | AU2014265353A1 (zh) |
CA (1) | CA2912700A1 (zh) |
HK (1) | HK1219308A1 (zh) |
MX (1) | MX2015015687A (zh) |
WO (1) | WO2014186607A1 (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2974373A1 (en) * | 2015-01-23 | 2016-07-28 | Unimed Biotech (Shanghai) Co., Ltd. | Microfluidics based fetal cell detection and isolation for non-invasive prenatal testing |
CN111500534B (zh) * | 2016-07-11 | 2022-11-29 | 山东亚大药业有限公司 | 分离纯化胎儿有核红细胞的试剂盒 |
EP3524687A4 (en) * | 2016-10-05 | 2019-11-06 | FUJIFILM Corporation | METHOD FOR DETERMINING THE NUMBER OF LOCUS REQUIRED AND METHOD FOR DETERMINING THE NUMBER OF SNP LOCUS REQUIRED |
EP4365597A2 (en) * | 2016-12-01 | 2024-05-08 | Nautilus Subsidiary, Inc. | Methods of assaying proteins |
EP3502274A1 (de) * | 2017-12-22 | 2019-06-26 | Attomol GmbH | Probenträger und verfahren zu dessen herstellung |
CN111500696B (zh) * | 2020-03-18 | 2023-03-14 | 中国科学院苏州生物医学工程技术研究所 | 基于飞行时间质谱检测孕妇外周血游离rna筛查21-三体综合征的试剂盒 |
CN113234163B (zh) * | 2021-07-13 | 2021-11-02 | 北京贝瑞和康生物技术有限公司 | 分离胎儿滋养层细胞的方法及试剂盒 |
CN115109780A (zh) * | 2022-06-22 | 2022-09-27 | 湖南大学 | 一种特异性识别并结合循环胎儿有核红细胞的核酸适体、互补序列及它们的应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5676849A (en) * | 1994-10-21 | 1997-10-14 | Bioseparations, Inc. | Method for enrichment of fetal cell population from maternal whole blood samples |
CN1476537A (zh) * | 2000-11-21 | 2004-02-18 | ���ŷ���������ѧУ��ѧЭ������ | 产前诊断早产、胎儿感染和胎儿损伤的诊断剂及含有它们的诊断试剂盒 |
CN102690786A (zh) * | 2012-06-05 | 2012-09-26 | 武汉格蓝丽富科技有限公司 | 一种细胞富集、分离、提取的方法和仪器及单细胞分析方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8980568B2 (en) * | 2001-10-11 | 2015-03-17 | Aviva Biosciences Corporation | Methods and compositions for detecting non-hematopoietic cells from a blood sample |
GB0509500D0 (en) * | 2005-05-10 | 2005-06-15 | Revealcyte | Method of fetal cell enrichment |
US20090081689A1 (en) * | 2007-09-25 | 2009-03-26 | Douglas Yamanishi | Reagents and methods to enrich rare cells from body fluids |
JP2011500070A (ja) * | 2007-10-31 | 2011-01-06 | アルケド バイオテック ゲーエムベーハー | 母性体液からの胎性細胞、胚性細胞及び核酸の分離・検出方法及び手段 |
-
2014
- 2014-05-15 KR KR1020157033713A patent/KR20160007542A/ko not_active Application Discontinuation
- 2014-05-15 JP JP2016514099A patent/JP2016521134A/ja active Pending
- 2014-05-15 US US14/784,943 patent/US20160053317A1/en not_active Abandoned
- 2014-05-15 CA CA2912700A patent/CA2912700A1/en not_active Abandoned
- 2014-05-15 MX MX2015015687A patent/MX2015015687A/es unknown
- 2014-05-15 CN CN201480027992.5A patent/CN105324666B/zh active Active
- 2014-05-15 AU AU2014265353A patent/AU2014265353A1/en not_active Abandoned
- 2014-05-15 EP EP14798490.0A patent/EP2997370A4/en not_active Withdrawn
- 2014-05-15 WO PCT/US2014/038250 patent/WO2014186607A1/en active Application Filing
-
2016
- 2016-06-23 HK HK16107291.3A patent/HK1219308A1/zh unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5676849A (en) * | 1994-10-21 | 1997-10-14 | Bioseparations, Inc. | Method for enrichment of fetal cell population from maternal whole blood samples |
CN1476537A (zh) * | 2000-11-21 | 2004-02-18 | ���ŷ���������ѧУ��ѧЭ������ | 产前诊断早产、胎儿感染和胎儿损伤的诊断剂及含有它们的诊断试剂盒 |
CN102690786A (zh) * | 2012-06-05 | 2012-09-26 | 武汉格蓝丽富科技有限公司 | 一种细胞富集、分离、提取的方法和仪器及单细胞分析方法 |
Non-Patent Citations (2)
Title |
---|
Identification of circulating fetal cell markers by microarray analysis;Marie Brinch 等;《Prenatal Diagnosis》;20121231;第32卷;第742页 * |
New technique using galactose-specific lectin for isolation of fetal cells from maternal blood;Michihiro Kitagawa 等;《PRENATAL DIAGNOSIS》;20021231;第22卷;第17-19页 * |
Also Published As
Publication number | Publication date |
---|---|
CN105324666A (zh) | 2016-02-10 |
US20160053317A1 (en) | 2016-02-25 |
EP2997370A4 (en) | 2017-01-18 |
MX2015015687A (es) | 2016-07-20 |
JP2016521134A (ja) | 2016-07-21 |
KR20160007542A (ko) | 2016-01-20 |
AU2014265353A1 (en) | 2015-11-12 |
WO2014186607A1 (en) | 2014-11-20 |
CA2912700A1 (en) | 2014-11-20 |
HK1219308A1 (zh) | 2017-03-31 |
EP2997370A1 (en) | 2016-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105324666B (zh) | 使用来自母体血液的胎儿细胞捕获的胎儿诊断学 | |
US11378498B2 (en) | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats | |
US20080026390A1 (en) | Diagnosis of Fetal Abnormalities by Comparative Genomic Hybridization Analysis | |
DK2029778T3 (en) | DIAGNOSIS OF Fetal ABNORMITIES | |
US8394582B2 (en) | Identification of fetal DNA and fetal cell markers in maternal plasma or serum | |
US20100167328A1 (en) | Blood cell separation | |
EP2389455A1 (en) | Methods and compositions for identifying a fetal cell | |
JP2005500861A (ja) | 細胞を単離する方法及びその使用 | |
WO2008014516A2 (en) | Selection of cells using biomarkers | |
CN102625854A (zh) | 用于检测染色体非整倍性的方法 | |
CN107206380A (zh) | 用于非侵入性产前测试的基于微流体的胎儿细胞的检测和分离 | |
US20060105353A1 (en) | Non-invasive prenatal fetal cell diagnostic method | |
EP3202912A1 (en) | Noninvasive method and system for determining fetal chromosomal aneuploidy | |
EP3192879A1 (en) | Method for detecting presence/absence of fetal chromosomal aneuploidy | |
Avent | Fetal genotyping | |
CN117248004A (zh) | Runx2多肽突变体在制备评估颅锁骨发育不良患者的试剂盒中的应用 | |
Abdullah | Blood group typing by molecular techniques: application to immunohaematology | |
AU2007229992A1 (en) | In situ hybridisation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170517 Address after: 201203 Shanghai city Pudong New Area Jing Road No. 199 room 321 Applicant after: BASETRA MEDICAL TECHNOLOGY CO.,LTD. Address before: 200233 building 15, building 481, 1 Guiping Road, Shanghai, Xuhui District Applicant before: Baishijia (Shanghai) Medical Technology Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Fetal diagnostics using fetal cells captured from maternal blood Effective date of registration: 20231201 Granted publication date: 20180727 Pledgee: Industrial Bank Co.,Ltd. Shanghai Changning sub branch Pledgor: BASETRA MEDICAL TECHNOLOGY CO.,LTD. Registration number: Y2023310000796 |